Primär Systemische Vaskulitiden (PSV)

Schlüsselwörter

ANCA-assoziierte Vaskulitis - Granulomatose mit Polyangiitis (vormals Wegenersche Granulomatose) - Mikroskopische Polyangiitis - Churg-Strauss-Syndrom - Polyarteriitis nodosa - Riesenzellarteriitis - Takayasu-Arteriitis - M. Behçet - Schönlein-Henoch-Purpura - leukozytoklastische Hautvaskulitis

Keywords

ANCA-associated vasculitis - Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Microscopic Polyangiitis - Churg-Strauss-Syndrome - Polyarteritis nodosa - Giant Cell Arteritis - Takayasu Arteritis - Behçet’s Disease - Henoch-Schönlein Purpura - Cutaneous Leucocytoclastic Vasculitis

• Literatur

• 1 Basu N, Watts R, Bajema I et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010; 69: 1744-1750
• 2 Both M, Nolle B, von Forstner C et al. Bildgebende Techniken zur Diagnostik primärer Großgefäßvaskulitiden. Teil 1: Angiographie, interventionelle Therapie und Magnetresonanztomographie. Z Rheumatol 2009; 68: 471-484
• 3 Davatchi F, Shahram F, Chams-Davatchi C et al. Behcet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis 2010; 13: 367-373
• 4 de Menthon M, Mahr A. Treating polyarteritis nodosa: current state of the art. Clin Exp Rheumatol 2011; 29: 110-116
• 5 Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008; 3: 25
• 6 Guerry MJ, Brogan P, Bruce IN et al. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2011; doi: 10.1093/rheumatology/ker150
• 7 Hajj-Ali RA, Singhal AB, Benseler S et al. Primary angiitis of the CNS. Lancet Neurol 2011; 10: 561-572
• 8 Hatemi G, Silman A, Bang D et al. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 2008; 67: 1656-1662
• 9 Hellmich B, Flossmann O, Gross WL et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-617
• 10 Herlyn K, Hellmich B, Gross WL et al. Stable incidence of systemic vasculitides in schleswig-holstein, Germany. Dtsch Arztebl Int 2008; 105: 355-361
• 11 Holle JU, Gross WL, Holl-Ulrich K et al. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?. Ann Rheum Dis 2010; 69: 1934-1939
• 12 Holle JU, Gross WL, Latza U et al. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011; 63: 257-266
• 13 Holle JU, Moosig F, Gross WL. Therapiestrategien bei Vaskulitiden entsprechend den Empfehlungen der European League Against Rhematism (EULAR) und der European Vasculitis Study Group (EUVAS). Internist (Berl) 2011; 52: 671-681
• 14 Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
• 15 Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist 2008; 14: 341-354
• 16 Luqmani RA, Suppiah R, Grayson PC et al. Nomenclature and classification of vasculitis – update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol 2011; 164: 11-13
• 17 Mukhtyar C, Guillevin L, Cid MC et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323
• 18 Mukhtyar C, Guillevin L, Cid MC et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68: 310-317
• 19 Pagnoux C, Seror R, Henegar C et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010; 62: 616-626
• 20 Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005; 53: 93-99
• 21 Schmidt WA, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries. Rheumatology (Oxford) 2002; 41: 46-52
• 22 Schmidt WA. Myalgien bei Polymyalgia rheumatica, Arteriitis temporalis und anderen Vaskulitiden. Z Rheumatol 2009; 68: 446-450
• 23 Schonermarck U, Lamprecht P, Csernok E et al. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2001; 40: 178-184
• 24 Shahram F, Zarandy MM, Ibrahim A et al. Nasal mucosal involvement in Behcet disease: a study of its incidence and characteristics in 400 patients. Ear Nose Throat J 2010; 89: 30-33
• 25 Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52: 2926-2935
• 26 Walsh M, Merkel PA, Mahr A et al. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis. Arthritis Care Res (Hoboken) 2010; 62: 1166-1173
• 27 Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides?. Best Pract Res Clin Rheumatol 2005; 19: 191-207
• 28 WGET RG. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352: 351-361